Nations Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174K Hold
10,700
0.01% 745
2025
Q4
$180K Hold
10,700
0.01% 721
2025
Q3
$166K Hold
10,700
0.01% 689
2025
Q2
$137K Sell
10,700
-500
-4% -$6.16K 0.01% 664
2025
Q1
$142K Sell
11,200
-500
-4% -$6.77K 0.01% 638
2024
Q4
$154K Hold
11,700
0.01% 650
2024
Q3
$176K Hold
11,700
0.01% 650
2024
Q2
$166K Sell
11,700
-300
-3% -$4.06K 0.01% 611
2024
Q1
$164K Hold
12,000
0.01% 604
2023
Q4
$162K Hold
12,000
0.02% 600
2023
Q3
$150K Sell
12,000
-1,900
-14% -$25K 0.02% 592
2023
Q2
$188K Hold
13,900
0.02% 590
2023
Q1
$194K Hold
13,900
0.02% 587
2022
Q4
$198K Hold
13,900
0.02% 567
2022
Q3
$190K Buy
13,900
+2,200
+19% +$32.9K 0.03% 510
2022
Q2
$166K Hold
11,700
0.02% 506
2022
Q1
$194K Hold
11,700
0.02% 501
2021
Q4
$225K Hold
11,700
0.03% 446
2021
Q3
$243K Buy
+11,700
New +$250K 0.04% 397

Other funds holding HQL

Nations Financial Group's HQL Position: Q1 2026 in Review

Nations Financial Group held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 10,700 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #745.

Nations Financial Group first reported a position in HQL in Q3 2021 and has held it in 19 quarters since. The position peaked at $243K in Q3 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Nations Financial Group held 10,700 shares of abrdn Life Sciences Investors worth $174K as of Q1 2026.
  • Nations Financial Group left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
  • abrdn Life Sciences Investors made up 0.01% of Nations Financial Group's portfolio in Q1 2026, its #745 holding.
  • Nations Financial Group first reported a position in abrdn Life Sciences Investors in Q3 2021 and has held it in 19 quarters since.
  • Nations Financial Group's abrdn Life Sciences Investors position peaked at $243K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.